CANCER TESTS

Advertisement
Dec 01 2025BUSINESS

BillionToOne: A Closer Look at the Biotech Stock Surge

BillionToOne, a biotech company based in Menlo Park, has seen its stock price soar. As of Friday, shares were trading at $130. 18, a significant jump from the initial public offering price of $60. This surge values the company at $5. 91 billion. The company recently raised $273 million by selling 4

reading time less than a minute